A comparison of commercial and in-house ELISAS for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase

Pathology

Volumn 31, Issue 1, 1999, Pages 38-43

  Pollock, W ^a   Dunster, K ^b   Roland, J M ^b   Koh, H ^c   Savige, J ^d  

^a GRIBBLES PATHOLOGY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c Women's and Children's Healthcare Network   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

Antineutrophil cytoplasmic antibodies; Autoantibodies; ELISA; Indirect immunofluorescence; Myeloperoxidase; Proteinase 3

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; VASCULITIS;

EID: 0033042316     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130299105511     Document Type: Article

References (28)

1. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 1982; 285: 606.
2. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker for disease activity in Wegener's granulomatosis. Lancet 1985; i: 425-9.
3. Falk RJ, Jennette CJ. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. New Eng J Med 1988; 318: 1651-7.
4. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987; i: 1389-93.
5. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97 (Suppl): 12-3.
6. Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL. Wegener's autoantigen decoded. Nature 1990; 346: 520.
7. Hagen EC. Development and standardisation of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation. Clin Exp Immunol 1995; 101(S): 29.
8. Jennette JC, Falk RJ. Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol 1995; 101 (Suppl. 1): 18-22.
9. Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemee RA. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 1989; 64: 28-36.
10. Goeken JA. Antineutrophil cytoplasmic antibody - a useful serological marker for vasculitis. J Clin Immunol 1991; 11: 161-74.
11. Scott DGI, Sharrack BR, Webb FWS. Antineutrophil cytoplasmic antibodies and rheumatoid arthritis. Clin Exp Rheumatol 1990; 8: F24 (Suppl. 4).
12. Nassberger L, Sjohlm AG, Jonsson H, Sturfelt G, Akesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 380-3.
13. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202-10.
14. Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989; 76: 30-3.
15. Roozendaal C, Broekroelofs J, Horst G, Kleibeuker JH, Nelis GF, Limburg PC, et al. Prevalence and characterisation of ANCA in inflammatory bowel disease. Clin Exp Immunol 1995; 101 (Suppl): 70A.
16. Schellong SM, Boker KHW, Haubitz M, Manns M, Alexander K. Prospective study of pANCA in inflammatory bowel disease. Clin Exp Immunol 1995; 101 (Suppl): 45A.
17. Nolle B, Specks U, Ludemann J, Rohrbach MS, De Remee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989; 111: 28-40.
18. Cohen-Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-11.
19. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 1988; 82: 1963-73.
20. Audrain MAP, Beranger TAR, Lockwood CM, Esnault VLM. High immunoreactivity of lactoferrin contaminating commercially purified myeloperoxidase. J Immunol Methods 1994; 176: 23-31.
21. Bini P, Gabay JE, Yeitel A, Malchior M, Zhou J-L, Elkon KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognise conformational epitope(s) on proteinase 3. J Immunol 1992; 149: 1409-15.
22. Campanelli D, Melchior M, Fu Y, Nakata M, Shuman H, Nathan C, et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 1990; 172: 1709-15.
23. Short AK, Lockwood CM, Bollen A, Moguilevsky N. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis. Clin Exp Immunol 1995; 102: 106-11.
24. Falk RJ, Becker M, Terrell R, Jennette JC. Antimyeloperoxidase autoantibodies react with native but not with denatured myeloperoxidase. Clin Exp Immunol 1992; 89: 274-8.
25. Jayne DRW, Jones SJ, Severn A, Shaunak S, Murphy J, Lockwood CM. Severe pulmonary haemorrhage and systemic vasculitis associated with circulating antineutrophil cytoplasmic antibodies of IgM class only. Clin Nephrol 1989; 32: 101-6.
26. Esnault VLM, Solimani B, Keogan MT, Brownlee AA, Jayne DRW, Lockwood CM, Association of IgM with IgG ANCA in patients presenting with pulmonary haemorrhage. Kidney Int 1992; 41: 1304-10.
27. Segelmark M, Baslund B, Wieslander J. Some patients with antimyeloperoxidase antibodies have a cANCA pattern. Clin Exp Immunol 1994; 96: 458-65.
28. Zhao MH, Jones SJ, Lockwood CM. Bactericidal/permeability-increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995; 99: 49-56.